Introduction {#sec1}
============

Aesthetic outcome from breast cancer surgery has a well-documented influence on patients\' psychosocial wellbeing and quality of life \[[@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8]\]. With excellent survival expectations of 90% at one year and 80% at ten years \[[@bib9]\], more women experience the long term impact of treatments, reinforcing aesthetic outcome as an important survivorship focus. The guidance from the UK\'s National Institute for Health and Care Excellence (NICE) in 2002, that all women undergoing mastectomy in the UK should be offered reconstruction, reflects the acceptance of this in breast cancer surgery \[[@bib10]\].

Breast reconstruction is a rapidly developing field in the UK \[[@bib11]\], yet it is without a gold standard measure for reporting aesthetic outcome. A review by Potter et al. highlights many inconsistencies between the current methods for assessment of outcome \[[@bib13]\].

Patient reported outcome measures (PROMs) are an important reflection of aesthetic satisfaction, however, they do not correlate well with professional evaluation of aesthetics \[[@bib8],[@bib14], [@bib15], [@bib16]\] which frequently report more favourable outcomes \[[@bib17], [@bib18], [@bib19]\]. Qualitative interviews with patients who had undergone breast reconstruction shed some light on factors contributing to patients\' decision making. How a patient feels about their reconstruction and how they feel they are perceived by others\', the relationship with their surgeon or other practitioners, clinical outcome (i.e. complications) and how they viewed reconstruction as part of their cancer journey were described. A positive patient experience may translate into a favourable opinion of aesthetic outcome as measured by PROMs when a professional judgement may suggest the contrary, thus, PROMs may not be responsive enough to build clinical evidence and develop best practice \[[@bib20]\]. The impact of relationships and pathway on patient perception of outcome limits the value of PROMS in evaluation of existing and new techniques in order to innovate.

An objective scoring system would provide a robust method of communication, benchmarking, and comparison of aesthetic outcome, an important asset when considering new surgical techniques and materials, especially within today\'s context of 'no surgical innovation without evaluation' \[[@bib21], [@bib22], [@bib23]\]. Three Dimensional Surface Imaging (3D-SI) may represent the best modality for this as it provides quantitative information on projection, volume and surface symmetry in addition to linear mammometrics (distances from surface landmarks, i.e. sternal notch-to-nipple distance).

In order to develop an objective scoring system for 3D-SI, a gold standard is needed against which to perform multivariate analysis to discern how to weight each measured parameter. Panel assessment is the most widely accepted evaluation method, but has inherent bias, is costly, time-consuming, and not standardised. There are multiple panel scales reported in the literature which share common deficiencies, including lack of responsiveness, repeatability, and interpretability \[[@bib12],[@bib14]\]. Evaluating reconstructive surgery is arguably more challenging than for breast-conserving treatment (BCT) where the overarching goal is to maintain or achieve symmetry. In reconstructive surgery there is a broader spectrum of operative goals which can be tailored to the patient desires and surgical achievability (i.e. the capacity to modify size, shape, projection, cleavage, and the position of breast mound).

In this study, a Delphi consensus process was used to develop a contemporary scale for the panel assessment for breast reconstruction aesthetics. Enabling as a step towards the development of an objective scoring system using measures derived from 3D-SI \[[@bib24]\].

Methods {#sec2}
=======

This study was part of a pilot study reviewed by the London-Surrey Research Ethics Committee (17/LO/0763) in preparation for a large multi-centre trial, available at [clinicaltrials.gov](http://clinicaltrials.gov){#intref0010} (NCT03203252).

Delphi consensus process {#sec2.1}
------------------------

The purpose was to identify key aesthetic criteria used by clinicians when evaluating aesthetic outcomes. These items were developed into a panel scoring system, ultimately for use as the gold standard in development of an objective score for the evaluation of breast reconstruction using 3D-SI. A systematic review of current scales within the literature by Maass et al. \[[@bib12]\] and consultation with experts in the field shaped the online questionnaire for use in the Delphi consensus process. Items referenced in the literature which have been used in previous panel assessments for aesthetic evaluation after reconstructive breast surgery were included in the questionnaire. The questionnaire was circulated to oncoplastic and plastic surgeons via iBRA-net (a community of research active breast/plastic surgeons in the UK) and the UK Association of Breast Surgery (ABS). Participants were required to rate each item according to their perception of its importance for inclusion in an expert panel assessment for breast reconstruction, from 1 (extremely important) to 9 (unimportant).

The Delphi process consisted of two iterative rounds of voting with predefined exclusion criteria ([Fig. 2](#fig2){ref-type="fig"}), followed by two consensus discussions and a final round using binary "in" or "out" voting. Participants must have completed prior rounds in order to participate in subsequent rounds. The rationale for hosting two consensus discussions was pragmatic, to enable maximum participation. One was held in Birmingham at the iBRA-net meeting (October 2018) and the other in London at the Royal Marsden cross-site oncoplastic research meeting (November 2018). Only votes from members who had participated in rounds one and two contributed to the final round, although others contributed to the discussion.Fig. 1Standardised views of 3D-SIs viewed by the panel including Antero-posterior (AP), Oblique (left and right), Lateral (left and right), cranial, and caudal.Fig. 1

Additional questions posed within the questionnaire that were not part of the Delphi process pertained to the participant (profession, grade, experience \[years in post\], gender) and the proposed panel methodology (number of panellists, number of points on the Likert scale).

Evaluation of the aesthetic scoring system {#sec2.2}
------------------------------------------

The validity, intra- and inter-panellist and intra-panel reliability of the scoring system was tested by a multi-disciplinary panel with representation from two centres in London with high rates of autologous and implant reconstruction (Imperial College Healthcare NHS Trust and The Royal Marsden NHS Foundation Trust). Three oncoplastic breast surgeons, three clinical oncologists, and three plastic surgeons comprised the panel. The panellists were all consultants with at least 5 years\' experience in post. The panellists were blinded to patient, surgeon and clinical oncologist identity and the treatment received. Lay people and patients were not included because the aim was to select items which contributed to a better technical outcome, for benchmarking and research purposes.

3D-SIs of 55 women who had undergone mastectomy (unilateral or bilateral) and immediate autologous breast reconstruction with adjuvant or neoadjuvant radiotherapy were viewed in a standardised animation (7 views in sequence). Antero-posterior (AP), oblique (left and right), lateral (left and right), cranial, and caudal views were presented ([Fig. 1](#fig1){ref-type="fig"}). 10 3D-SIs were selected at random and repeated within the panel assessment to report upon intra-panellist and intra-panel reliability. No discussion was permitted during the panel assessment. The panel was not shown example images to benchmark standards. Panellists were given written definitions for the Likert scales in advance of the panel (also available during the panel assessment for reference) in order to standardise the scoring.

Three-dimensional surface images {#sec2.3}
--------------------------------

3D-SIs were captured using Vectra® (Canfield, USA). Women were positioned with their hands on their hips with their elbows behind the mid-axillary line to optimise visualisation of the lateral aspect of the breast. The images were taken at the end inspiratory pause during quiet breathing. Images for the adjuvant radiotherapy cohort were collected as part of a previous study \[[@bib14]\], and the images for the neoadjuvant group were from the aesthetic subgroup of the Primary Radiotherapy And Diep flap study (PRADA) \[NCT02771938\].

Statistics {#sec2.4}
----------

IBM SPSS 23 was used throughout. Delphi results were represented using simple descriptive statistics.

Intra-panellist and intra-panel reliability was reported using weighted kappa (wκ) for 10 repeated images. A wκ equal to 0 was considered to indicate poor agreement; 0.01--0.20 slight agreement; 0.21--0.40 fair agreement; 0.41--0.60 moderate agreement; 0.61--0.80 substantial agreement; 0.81--0.99 very good; and 1.00 perfect agreement.

Inter-panellist agreement was measured using the intra-class correlation coefficient (ICC). ICC of less than 0.40 was considered poor, between 0.40 and 0.59 fair, between 0.60 and 0.74 good and between 0.75 and 1.00 excellent \[[@bib25]\]. Internal consistency was evaluated using Cronbach\'s alpha (α). An α value of$\geq$ 0.9 translated to excellent internal consistency, $\geq$ 0.8 to \<0.9 good, $\geq$0.7 to \<0.8 acceptable, $\geq$0.6 to \<0.7 questionable, $\geq$0.5 to \<0.6 poor, and \<0.5 unacceptable \[[@bib26]\].

Using Spearman\'s correlation coefficient (r), the correlation between each item (shape, symmetry, volume, position of breast mound, nipple position) with the global score was used to test the validity of the method. For interpretation, r of $\geq$0.9--1.0 ($\leq$−0.9 to −1.0) very high positive (negative) correlation, $\geq$0.7 to 0.9 ($\leq$−0,7 to −0.9) high positive (negative), $\geq$0.5 to 0.7 ($\leq$−0.5 to −0.7) moderate positive (negative), $\geq$0.3 to 0.5 ($\leq$−0.3 to −0.5) low positive (negative), 0.3 to −0.3 negligible correlation \[[@bib27]\]. Spearman\'s correlation coefficient was also used to assess the correlation between the global score and PROMs (BREAST-Q satisfaction with breasts Q-score 0--100, where 100 is the best score).

Results {#sec3}
=======

The Delphi consensus process {#sec3.1}
----------------------------

61 surgeons (88% consultants) completed round one, 49 round two, and 18 were involved in both the consensus discussion and final voting round ([Fig. 2](#fig2){ref-type="fig"}). Oncoplastic and plastic surgeons were represented (75% and 25% respectively). 46 were consultant oncoplastic surgeons (1 retired), 11 consultant plastic surgeons, and 4 were trainees. 19 (31%) had spent \<3 years in their current post, 12 (20%) 3--5 years, 11 (18%) 6--10 years, 19 (31%) \>10 years. 28 (46%) were male, 30 (29%) female, 1 (2%) transgender, and 2 (3%) preferred not to say.Fig. 2The Delphi consensus process.Fig. 2

Round one voting reduced the number of items included in the questionnaire from 20 to 17, and round two from 17 to 13, the final round established 5 items (surface symmetry, volume, shape, position of breast mound, nipple position) in addition to a global score for the Delphi-derived panel evaluation ([Table 1](#tbl1){ref-type="table"}). The majority voted for a 5-point Likert scale, and 3--5 panellists to comprise the panel.Table 1Progression of scales through the Delphi rounds with percentage voting important (1--3) and unimportant (7--9) in rounds 1 and 2 and percentage voting to keep or exclude each scale in round 3. The parameters for retaining items is explained.Table 1Round 1 (n = 61)Round 2 (n = 47)Round 3 (n = 18)ItemVoted Important 1--3 (%)Voted Unimportant 7--9 (%)Progress to next round \>50% vote important or \< 15% vote unimportantVoted Important 1--3 (%)Voted Unimportant 7--9 (%)Progress to next round \>60% vote important or \< 20% vote unimportantPercentage voting to keep the item (%)Item used in final scale \>70% voted 'in'Symmetry8213Yes7721Yes100YesGlobal8211Yes7221Yes83YesShape8010Yes6615Yes89YesPosition of breast mound7915Yes6426Yes72YesVolume7411Yes6819Yes89YesNatural look7411Yes4923No----Nipple position6915Yes6417Yes72YesFibrosis6711Yes5115Yes22NoContour6416Yes5517Yes55NoProjection597Yes4015Yes61NoAppearance of upper pole5915Yes4023No----Contracture5711Yes4313Yes28NoScar5413Yes3717Yes17NoIMF height5210Yes4717Yes44NoFocal volume deficit or excess5213Yes4519No----Appearance of NAC5111Yes3817Yes22NoSkin paddle appearance3811Yes2323No----Implant edge3615No----------Skin colour match3423No----------Shape of areola3321No----------

The detailed description of scores for each item used in the panel evaluation is illustrated in [Table 2](#tbl2){ref-type="table"}. The rationale is not only to guide the panellists but to aid in the interpretation of the result making the process more clinically relevant.Table 2Likert scale description used for reference during the panel assessment.Table 2Excellent 5Good 4Moderate 3Poor 2Very Poor 1ShapeThe overall shape of the reconstructed breast/sShape symmetry out of bra achievedShape of operated breast is pleasing but ***not symmetrical***Moderate difference in shape but does ***not*** detract from overall aesthetic resultModerate focal deficits ***detracting*** from overall aesthetic resultLarge focal deficits ***distorting contour*** significantly detracts from overall aesthetic resultVolumeOverall volume symmetry between breastsEqual volume between breastsMinor difference in volumeModerate difference in volume but does ***not*** detract from overall aesthetic resultVolume difference impacts overall aesthetic resultMajor volume mismatch significantly detracts from overall aesthetic resultNipple PositionNipple position in relation to the ipsilateral breastExcellent symmetry between sides and nipple in an ideal position on reconstructed breast moundMinor adjustments required to achieve excellence in nipple positionNoticeably suboptimal but does ***not*** influence overall aesthetic resultsNipple position slightly impacts overall aesthetic resultNipple position significantly detracts from overall aesthetic resultProjectionPatient view of symmetryProjection is **equal**Minor differences in projectionNoticeable difference but ***not*** detracting from overall aesthetic resultSlightly impacts overall aesthetic resultSignificantly detracts from overall aesthetic resultPosition of Breast MoundIn relation to chest wall and other breastEqual to the other side ***and*** in an optimal position on chest wallMinor asymmetry of position ***or*** symmetrical but suboptimal positionAsymmetry of position ***or*** symmetrical but suboptimal position ***not*** detracting from overall aesthetic resultSlightly impacts overall aesthetic resultSignificantly detracts from overall aesthetic resultSymmetryComparison between breastsOut of bra symmetry achievedMild asymmetryModerate asymmetry but does ***not*** detract from overall aesthetic resultModerate asymmetry detracting from overall aesthetic resultSignificant asymmetry detracting from overall aesthetic resultGlobalTaking into consideration subscale evaluation what is your overall impression of the quality of the reconstructionExcellentGoodModeratePoorVery Poor

Reliability of the panel methodology {#sec3.2}
------------------------------------

### Intra-panellist reliability {#sec3.2.1}

The intra-panellist reliability varied from poor to almost perfect agreement across the individual items (wκ\<0 to 0.86), with better agreement for symmetry, volume, and the global score.

### Inter-panellist reliability {#sec3.2.2}

The ICC could not be calculated for nipple position because there were too few cases i.e. the majority of women in the images had not had NAC conservation or reconstruction. The ICC for the other individual items was fair (range 0.4--0.5) and was good (0.6) for the global score ([Table 3](#tbl3){ref-type="table"}). Cronbach\'s alpha was good to excellent.Table 3Inter-panellist agreement and internal consistency of the panel methodology per scale. ICC; intra-class correlation coefficient.Table 3ItemCronbach\'s alphaICC (single measures)SignificanceICC (average measures)SignificancePosition of Breast Mound0.9310.51\<0.010.903\<0.01Nipple position----------Symmetry0.9180.511\<0.010.904\<0.01Volume0.8920.432\<0.010.872\<0.01Shape0.9060.466\<0.010.887\<0.01Global0.9380.564\<0.010.921\<0.01

### Intra-panel reliability {#sec3.2.3}

Intra-panel reliability for 10 repeated images showed moderate to substantial agreement between the mean panel score for the two occasions when the images were shown (range wκ0.4--0.7). Shape and symmetry demonstrating the strongest agreement ([Table 4](#tbl4){ref-type="table"}).Table 4Intra-panel agreement using quadratic weighted kappa for each subscale for 10 repeated images. The mean panel score was used for evaluation.Table 4ItemWeighted kappaPosition of breast mound0.4Nipple areola complex--Symmetry0.7Volume0.4Shape0.7Global0.5

### Validity {#sec3.2.4}

Each item (shape, symmetry, volume, position of breast mound, nipple position) independently showed a high or very high positive correlation with the global score (range r = 0.88--0.92).

### Panel evaluation and PROMs {#sec3.2.5}

There was a statistically significant but only moderate strength positive correlation between the mean global panel score and the 'satisfaction with breasts' domain of the BREAST-Q post-operative reconstruction module (r = 0.5 p \< 0.01).

Discussion {#sec4}
==========

The rationale for the development of this scale is primarily as the gold standard against which an objective measure of aesthetic outcome for breast reconstruction can be developed using measures derived from 3D-SI in a future multicentre study. 3D-SI may provide a highly reliable and robust way to communicate aesthetic outcome to enable comparison of results, benchmarking, and development of best practice guidelines, but a robust gold standard is required, against which to test these measurements.

This paper describes the successful development of a reliable, contemporary scale for evaluating breast aesthetic outcomes as captured on 3D-SI. The scale is designed specifically for breast reconstruction and was developed through a Delphi consensus process using expert oncoplastic and plastic breast surgeons. The strengths include the robust development of the scoring criteria using the Delphi process incorporating a literature review with opinion from experts representing different centres across the UK. The scale was developed specifically for breast reconstruction and has been tested by a multi-disciplinary panel. Careful consideration of the written descriptors for each individual item enabled panellists to have a clear understanding of what each score represented clinically. This is also important when interpreting scores to ensure a qualitative meaning can be gleaned from a quantitative score.

A systematic review by Maas et al. employed the modified Medical Outcomes Trust (MOT) criteria to evaluate the professional aesthetic assessment scales referenced in the literature \[[@bib12]\]. The MOT criteria evaluate each scale based on a predefined scoring system encompassing 7 domains including development of the framework, reliability, validity, responsiveness, interpretability, burden (for professional and patient), and correlation to PROMs. The maximum score is 7. The aesthetic evaluation scale scoring most highly in the review by Maas (4.5 out of 7) was the ten-point Visser scale which includes 5 subscales (volume, symmetry, scar, nipple-areola complex, shape) and a global ten-point (Likert) scale. The Vrieling scale which incorporates 6 subscales (scar, size, shape, nipple position, shape of areola, skin colour) and a global four-point Likert scale from 0, excellent to 3, poor, was the most commonly referenced in the literature and scored 3 out of 7 \[[@bib12]\]. When the MOT criteria was applied to the scale in this study, a comparable score of 5 results. Thus, until the 3D-SI objective scoring system is available, this Delph-derived scale provides a robust alternative.

As with all panel assessments, some logistical constraints remain. The strict non-discussion policy during panel assessment was designed to mimic conditions of a 'virtual panel' i.e. independently viewing and scoring of images from a remote location, which would surmount the majority of logistical challenges associated with traditional panel assessment and potentially reduce the burden for panellists (travel, inconvenience). Discussion permits a level of benchmarking between panellists, as hearing the opinions of others may lead to re-evaluation of an individual\'s scoring. If this variation was significant it would be reflected in the inter-panellist variability i.e. it would be worse with no discussion.

There is a wide range of inter-panellist variability reported in the literature often using different statistical tests rendering comparison challenging. Visser et al. report an ICC ranging from poor to excellent (0.17--1) for the ten-point scale \[[@bib28]\], and Vrieling et al. report moderate inter-rater reliability (κ0.55) \[[@bib29]\], and the linear numeric analogue scale (the second highest scoring scale in the Maas review) reports inter-rater agreement of 0.23--0.38. Inter-rater variability using the Visser scale for a similar cohort of patients scored in our unit was "moderate" (wκ0.4) for the global score and ranged from wκ0.2--0.36 for the subscales \[[@bib14]\]. The inter-rater reliability for the method developed in this paper ranged from an ICC of 0.4--0.5 for the subscales and 0.6 for the global score, in line with the best scoring other scales suggesting remote panel assessment is a feasible alternative.

The number of experienced surgeons participating in the Delphi consensus was good, however, the inclusion of clinical oncologists would perhaps have broadened the experience and provided additional elements for consideration. The concept was to design a panel to represent expert opinion on aesthetic outcome, hence the intentional exclusion of patient representation. Patient reported evaluation of aesthetics is consistently discordant with expert opinion hence the need to separate the two \[[@bib28],[@bib30],[@bib31]\].

The Delphi-derived panel evaluation described in this paper was compared with PROMs, demonstrating a moderate correlation. Comparison between PROMs and expert panel evaluation is reported in the literature but it is difficult to draw reliable conclusions due to the different scales and methods of comparisons used. Ramon et al. report moderate correlation between the ten-point Visser scale with PROMs using spearman\'s correlation co-efficient (r = 0.48) \[[@bib32]\] which is comparable to the results observed here (r = 0.5). The PROMs used in that study were in the form of a study specific questionnaire rather than the validated and widely used BREAST-Q which was used here.

Conclusions {#sec5}
===========

We have successfully harnessed expert opinion to develop and test a scale for the expert evaluation of aesthetic outcome after breast reconstruction. This Delphi-derived panel evaluation is at least as good as other scales referenced in the literature and has been developed specifically for future use as a gold standard against which objective outcomes scores can be tested. The logistical flaws of panel assessment remain, giving weight to the importance of the development of an objective way to report upon aesthetic outcomes.
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